Objectives: Long non-coding RNAs (lncRNAs) are characterized as a group of RNAs that more than 200 nucleotides in length and have no protein-coding function. More and more evidences provided that lncRNAs serve as key molecules in the development of cancer. Deregulation of lncRNAs functions as either oncogenes or tumour suppressor genes in various diseases. Recently, increasing studies about PANDAR in cancer progression were reported. In our review, we will focus on the current research on the character of PANDAR include the clinical management, tumour progression and molecular mechanisms in human cancers.
Approximately 70% of human genome is transcribed into RNA, however, only less than 2% of the human genome codes for protein. 3, 4 Recent study showed non-coding RNAs (ncRNAs) are transcribed from non-protein-coding DNA sequences and key regulatory RNAs. 5 Long non-coding RNAs (LncRNAs) belong to ncRNAs that are longer than 200 nucleotides in length. 6 Previous studies suggested that the lncRNAs acted as transcriptional modulator, splicing regulator, post-transcriptional processor, enhancer, molecular decoys for miRNAs, chromatin remodeler, a guide for protein-protein, protein-DNA and protein-RNA interactions. 7, 8 For instance, H19 was one of the first reported long non-coding RNAs. It was enhanced in breast, urological, respiratory and brain tumours. H19 could function in trans to suppress the levels of a number of imprinted genes in the hypothesized Imprinted Gene Network (IGN) including Igf2r and.
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LncRNA HOX antisense intergenic RNA(HOTAIR) was upregulated in breast cancer, gastric cancer and hepatocellular carcinoma. [11] [12] [13] HOTAIR causes the transcriptional suppressing of the HOXD locus on chromosome 2 in trans. 14 It recruits polycomb repressiving complex 2 (PRC2) and regulates the chromosome occupancy of EZH2 (a subunit of PRC2), which causes histone H3 lysine 27 trimethylation of the HOXD locus.
Accumulating evidence indicates that lncRNAs are frequently deregulated in many kinds of cancer, playing critical roles in tumourigenesis.
According to the function of lncRNAs in diverse cancer types, they can be classified into tumour suppressors or oncogenes. 15, 16 MEG3 and GAS5
are famous tumour suppressor lncRNAs. [17] [18] [19] HOTAIR, MALAT-1, ATB, SPRY4-IT1 and CCAT2 are well-known oncogenic lncRNAs, which can induce tumourigenesis. 16, [20] [21] [22] [23] LncRNAs take part in various aspects of cell biology and not doubt that contribute to tumour development potentially through stimulating or inhibiting cell proliferation, apoptosis, differentiation, invasion and metastasis. 24 Dysregulation of lncRNAs leads to tumour formation, contributing to cancer development, progression and metastasis.
In recent years, more and more evidences demonstrated the tissue-specific expression of P21-associated ncRNA DNA damage ac- 
| PANDAR IN VARIOUS CANCERS

| Colorectal cancer
Colorectal cancer (CRC) is the third most famous cancer in the world, which becomes the fourth most usual cause of cancer-related deaths. 25 Cancer metastasis is the major reason for high mortality of to suppress anti-apoptotic impact. 30 Experiment results indicated that knockdown of PANDAR inhibited the levels of Bcl-2 and reinforced the levels of Bax. In other hand, previous studies suggested that epithelial mesenchymal transition (EMT) was one of important mechanism in cell migration and invasion. 31 When PANDAR was knockdowned in colorectal cancer cell lines, the levels of N-cadherin, vimentin, β-catenin, Snail and Twist were observably inhibited, but the levels of E-cadherin were meaningfully enhanced. Above results suggested that the underlying mechanisms of PANDAR may be car- 
| Lung cancer
Lung cancer is the most frequent cause of cancer-related death worldwide. 35 Approximately 80-85% of lung cancer patients are diagnosed
with non-small cell lung cancer (NSCLC). 36 Despite of advances in exanimation and new therapies for lung cancer, prognosis of NSCLC remains unsatisfied, and metastasis and recurrence are the main causes for poor prognosis. However, vast majority of NSCLC patients unfortunately are diagnosed at an advanced stage. Therefore, it is necessary to disclose the molecular mechanisms of NSCLC to diagnose and develop effective therapies.
The levels of PANDAR were meaningfully correlated to NSCLC.
Han et al 37 found the expression of PANDAR was generally decreased In addition, overexpression of PANDAR showed the decreased NF-YA binding at the promoter of Bcl-2. These data revealed that Bcl-2 might be the key of PANDAR/NF-YA-regulated genes. In a word, Bcl-2 enhances tumour proliferation and restrains apoptosis in a way because of downregulation of PANDAR by releasing NF-YA and inducing P53.
In summary, PANDAR may show as a new therapeutic biomarker in the future. (Figure 2 ).
| Renal cell carcinoma
Renal cell carcinoma (RCC) contributes to about 3% of all human cancer, which on behalf of the most fatal urological cancer with nearly 202 000 cases and 102 000 deaths worldwide. 41 The incidence of RCC has sharply increased for over 20 years, 42 Knockdown of PANDAR-induced RCC cell cycle arrested at the G0/G1 phase, oppositely, decreased at the S phase. Further experimental showed that the levels of cyclin E1, CDK4 and cyclin D1were dramatically decreased, oppositely, P21 was markedly increased when PANDAR was silenced. In conclusion, knockdown of PANDAR might regulate the Cyclin-CDKs signal pathway inducing cell cycle arrested at the G0/G1 phase partly.
Moreover, caspase-3 and PARP, kinds of apoptosis-associated proteins, were detected cleaved after downregulation of PANDAR. In addition, Bcl-2 family proteins were associated with cell apoptosis closely in various cancers. Silenced PANDAR showed the levels of Mcl-1 and Bcl-2 were decreased, oppositely, Bax was increased. Previous studies disclosed PI3K/Akt/mTOR pathway took part in cell proliferation and apoptosis in many human tumours. 48 The authors revealed that knockdown of PANDAR decreased the levels of mTOR and the phosphorylation of PI3K and Akt. Taken together, the authors disclosed that PANDAR-induced RCC cell apoptosis by regulating Bcl-2 family proteins and PI3K/Akt/mTOR pathway. In summary, PANDAR may be a novel therapeutic biomarker for RCC patients in the future (Figure 3 ).
| Breast cancer
Breast cancer usually comes from mammary gland epithelial tissue, which is the most famous cancer and the most frequent cause of cancer death among women universally. 49 It was estimated that about 1.67 million new cases of breast cancer were diagnosed in 2012 contributing to 25% of all cancers, while 522 000 died from the disease.
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It is a very complex process that the progression of breast cancer is linked with many signalling pathways. Therefore, a better understanding of molecular pathways in breast cancer can detect the disease at an early stage and provide potential therapies.
Song et al 51 found the expression of PANDAR was increased both in breast cancer tissue and cell lines. To investigate the effects of F I G U R E 2 Bcl-2 boosts tumour cell proliferation and inhibits apoptosis in part due to the downregulation of lncRNA PANDAR, which releases the NF-YA and induces the downregulation of P53 PANDAR, the authors silenced PANDAR and detected a meaningfully inhibited cell growth. Moreover, they examined the levels of PANDAR in breast cancer cells cycle. The levels of PANDAR increased from G1 to S phase. It had no obvious change at G2, M and G1 phases.
Contrarily, knockdown of PANDAR repressed G1 to S transition.
Furthermore, they explored potential signalling pathway regulated by PANDAR. The result showed that downregulation of PANDAR could enhance the levels of P16. Moreover, co-transfection with P16 could reverse the increase of G1 phase ration by knockdown of PANDAR partly. In a word, it suggested that PANDAR might enhance the G1 to S transition by decreasing the levels of P16. Previously studies revealed that the levels Bmi1 were boosted in various human tumour, related to cancer clinical stage and poor prognosis. 52 It could directly inhibit the expression of P16. 53 PANDAR was upregulated by silencing Bmi1.
Experiment results indicated silence of PANDAR-induced downregulation of Bmi1 binding at the promoter of P16. In summary, it suggested that PANDAR might be a significant biomarker regulating the progression of breast cancer.
| Cholangiocarcinoma
Cholangiocarcinoma (CCA) most occurs from epithelium of hepatic biliary trees. 54 From the past until now, the incidence of CCA increased constantly in population worldwide. Major patients are at the advanced stages and unable to undergo surgical because of seriously invasive and metastatic characteristics of CCA. Moreover, surgical intervention carries a significantly higher recurrence rate. Radical resection may be the only one effective treatment at present. 55 Thus, novel biomarkers and effective therapeutic targets for the effectively detection and treatment of CCA are absolutely needed.
Xu et al 56 found that the levels PANDAR were meaningfully 
| Osteosarcoma
Osteosarcoma (OS) is the most famous primary malignant bone tumour, which occurring generally in adolescents and young adults. Previously results showed that over 20% of the young-onset osteosarcoma patients presented with distant metastases at diagnosis, and more than 40% cases at advanced stages progress to metastasis during therapy. 58 Patient life quality has been improved; thanks to the neoadjuvant chemotherapy. However, the toxicity, lung metastases and in situ recurrence still threaten many osteosarcoma patients. 59 Therefore, it is necessary to discover and develop new prognostic targets in monitoring progression and survival of osteosarcoma in clinic.
Kotake et al 60 
| Thyroid cancer
Thyroid cancer (TC), is one of the most usual malignant tumours of endocrine organs, originating from follicular or parafollicular thyroid cells. 62 It was reported that TC was steadily increasing in morbidity and mortality over the years. According to epidemiological data, the incidence of TC has been increased by an average of 4.5% per year from 2007 to 2011 in the United States. 63 Radiation, chemotherapy and surgery are the common treatment methods for thyroid cancer, unfortunately they all produce poor satisfaction. Therefore, it is urgent to explore precise diagnostic biomarkers and effective therapeu- 
| Other cancers
The levels of PANDAR were also enhanced involve hepatocellular carcinoma, gastric cancer and bladder cancer. Peng et al 65 
